Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sexual functioning and SSRIs.

Maurizio Fava1, Meridith Rankin

  • 1Depression Clinical and Research Program, Massachusetts General Hospital, Boston 02114-3117, USA.

The Journal of Clinical Psychiatry
|April 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder.

International clinical psychopharmacology·2015
Same author

A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDER.

Depression and anxiety·2015
Same author

A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders.

The primary care companion for CNS disorders·2015
Same author

The pro-inflammatory profile of depressed patients is (partly) related to obesity.

Journal of psychiatric research·2015
Same author

Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study.

Journal of psychiatric research·2015
Same author

Implications of a Biosignature Study of the Placebo Response in Major Depressive Disorder.

JAMA psychiatry·2015

Selective serotonin reuptake inhibitors (SSRIs) can cause sexual dysfunction, a common side effect. While some treatments show promise, more placebo-controlled studies are needed to confirm their effectiveness for SSRI-induced sexual side effects.

Area of Science:

  • Pharmacology
  • Psychiatry
  • Sexual Medicine

Background:

  • Reduced sexual functioning is a common symptom of depression, often improving with antidepressant treatment.
  • However, sexual dysfunction is also a significant side effect associated with various antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs).

Purpose of the Study:

  • To review the existing literature on the relationship between sexual functioning and SSRI use.
  • To explore potential pharmacological interventions for managing SSRI-induced sexual dysfunction.

Main Methods:

  • Literature review of studies investigating SSRI-associated sexual dysfunction.
  • Analysis of anecdotal case reports and limited clinical trials on counteracting interventions.

Related Experiment Videos

Main Results:

  • SSRI use is frequently linked to sexual dysfunction, despite their efficacy in treating depression.
  • Pharmacological interventions including serotonin receptor antagonists, a2-adrenergic receptor antagonists, and dopaminergic agents have been anecdotally reported as helpful.
  • An open trial indicated potential utility of oral sildenafil for antidepressant-associated sexual side effects.

Conclusions:

  • SSRI-induced sexual dysfunction is a prevalent issue requiring further investigation.
  • Robust, placebo-controlled studies are essential to establish the efficacy of interventions for managing these side effects.
  • Sildenafil shows preliminary promise, but requires additional research for definitive conclusions.